Metraipolis › archive › dc_ee0dfbc4b401
Japanese encephalitis: Current status, recent progress, and persistent challenges — Europe PMC PMID:42611910
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42611910
- DOI
- 10.1371/journal.pntd.0014641
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T07:55:25.064Z
- SHA-256 of the archived text
775bb1e72ba86da09da85ce5a5f6f45d8649ffb0d70969574f708e781daa067a- Stable URL of this page
https://metraipolis.com/documento/dc_ee0dfbc4b401
How to cite
Japanese encephalitis: Current status, recent progress, and persistent challenges — Europe PMC PMID:42611910 — Europe PMC (en), https://europepmc.org/article/MED/42611910 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ee0dfbc4b401 (Metraipolis archive dc_ee0dfbc4b401, sha256 775bb1e72ba86da09da85ce5a5f6f45d8649ffb0d70969574f708e781daa067a)
BibTeX
@misc{dcee0dfbc4b401,
title = {Japanese encephalitis: Current status, recent progress, and persistent challenges — Europe PMC PMID:42611910},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42611910},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ee0dfbc4b401; sha256 775bb1e72ba86da09da85ce5a5f6f45d8649ffb0d70969574f708e781daa067a},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/42611910. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Japanese encephalitis (JE), a mosquito‑borne, vaccine‑preventable disease, is endemic to much of Asia and parts of Oceania. Its main clinical manifestation, encephalitis, is associated with a 20-30% case-fatality rate and long-term sequelae in 30%-50% of survivors. During the past two decades, substantial progress has been made in JE prevention and control. Notably, several countries have introduced JE vaccine into their national immunization programs, leading to marked reductions in morbidity and mortality. Nonetheless, major challenges remain, particularly because the disease cannot be eradicated meaning high-quality, long-term JE vaccination programs must be maintained. In addition, JEV has emerged in an increasingly wide geographic area, including in widespread parts of Australia, and shifts in the age distribution of cases towards adults in some JE-endemic areas have occurred. In this review, we summarize current knowledge on JE, outline recent advances in prevention and control, and describe key persisting and emerging concerns. Addressing these issues and continuing efforts to strengthen JE immunization programs will be important to reducing the burden of this disease for populations in endemic areas now and in the future. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS neglected tropical diseases, 2026 (prima pubblicazione 2026-08-18). Identificativi: PMID 42611910 · PMCID PMC13485019 · DOI 10.1371/journal.pntd.0014641. Descrittori MeSH principali: Encephalitis, Japanese; Japanese Encephalitis Vaccines. Pagina: https://europepmc.org/article/MED/42611910 — https://doi.org/10.1371/journal.pntd.0014641. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T07:47:50.152Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.